Health care analysis on myocardial revascularization in patients with chronic coronary heart disease (CHD)

• Conditions: Chronic CHD in the form of a 2- or 3-vessel or main-vessel disease; I25; Chronic ischaemic heart disease

• Registration Number: DRKS00022175
• Lead Sponsor: InGef – Institut für angewandte Gesundheitsforschung Berlin GmbH (InGef)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2020-08-27
• Study Completion: 2023-01-31
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 386

Inclusion Criteria

Patients
(a) with chronic coronary heart disease and
(b) 2- or 3-vessel or main-vessel disease
(c) who are being treated at one of the recruitment sites
(d) with a promptly planned intervention for myocardial revascularization

Exclusion Criteria

missing informed consent

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Guidelines-compliant therapy in patients with chronic CHD (2- or 3-vessel or main vessel disease) according to NVL cKHK

Secondary Outcome Measures

Name	Time	Method
Frequency and quality of heart teams; extent of patient participation in the decision making process; importance of clinical parameters in the decision-making process (e.g. syntax scores, iFR, FFR)